Maribel Torres
Family · Visalia, CANPI 1427606169
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Johnson & Johnson at 51.7% of the total. 2025 is the largest year on record at $32,747, more than ten times the $2,753 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $149.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$29K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$10K
- Ipsen Biopharmaceuticals, Inc$4K
- Madrigal Pharmaceuticals$4K
- AbbVie$3K
- Gilead$2K
- plus $5K from 18 others
What the payments were for
- Consulting fees$6,94812%
- Speaking & faculty fees$26,89747%
- Travel & lodging$5,77010%
- Food & beverage$17,22730%
- Education$1980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 75 | $29,466 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 102 | $9,503 |
| Ipsen Biopharmaceuticals, Inc | 16 | $3,943 |
| Madrigal Pharmaceuticals | 24 | $3,656 |
| AbbVie | 51 | $3,158 |
| Gilead | 35 | $2,495 |
| Novo Nordisk | 6 | $730 |
| Ardelyx, Inc. | 23 | $681 |
| Lilly USA, LLC | 6 | $465 |
| Phathom Pharmaceuticals, Inc. | 6 | $455 |
| Exact Sciences | 3 | $317 |
| Regeneron Healthcare Solutions, Inc. | 4 | $268 |
| Aimmune Therapeutics, Inc. | 4 | $249 |
| E.r. Squibb & Sons, L.L.C. | 2 | $239 |
| Antares Pharma, Inc. | 2 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $210 |
| Sanofi | 2 | $199 |
| Ironwood Pharmaceuticals, Inc | 2 | $186 |
| Bristol Myers Squibb | 3 | $153 |
| Mirum Pharmaceuticals, Inc. | 1 | $128 |
| Pfizer | 1 | $127 |
| QOL Medical, LLC | 1 | $122 |
| Evoke Pharma, Inc. | 3 | $44 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$57,039 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 89 | $50,806 |
| ZenpepLipase/Protease/Amylase | 16 | $33,913 |
| Dexlansoprazole DrDexlansoprazole | 107 | $18,257 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 37 | $5,427 |
| Sucralfate | 36 | $3,046 |
| Famotidine | 184 | $1,396 |
| Esomeprazole Magnesium | 41 | $1,237 |
| Pantoprazole Sodium | 77 | $423 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 27 | $419 |
| Clarithromycin | 15 | $401 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 23 | $322 |
| Ondansetron Hcl | 14 | $245 |
| Omeprazole | 14 | $134 |
| Amoxicillin | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $3,158 | $50,80689 claims |
| Aimmune Therapeutics, Inc.Zenpep | $249 | $33,91316 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCPlenvu | $9,503 | $5,42737 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Visalia
- Pamela ScottVisalia$165K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.